Skip to content

Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m

Chronic vs. Acute Ingestion of Sodium Citrate: a Randomised Placebo Controlled Cross-over Trial for Swimming a 200 Metres in Well-trained Swimmers Age 13-17

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01835912
Enrollment
10
Registered
2013-04-19
Start date
2012-09-30
Completion date
2013-04-30
Last updated
2014-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alkalosis

Keywords

performance, speed, exertion

Brief summary

Ingestion of sodium citrate (Na-Cit), an alkalizing agent, increases extracellular pH via liver oxidation by decreasing \[H+\] and increasing bicarbonate concentration (HCO3-). Studies have confirmed that increasing extracellular pH promotes the efflux of La- and H+ from active muscles. This is due to an increase in activity of the pH sensitive monocarboxylate transporter as the gradient of intracellular versus extracellular H+ increases. Therefore, artificially inducing alkalosis prior to anaerobic exercise may reduce intracellular acidosis and increase the time to fatigue - defined as a decrease in force production with an increased perception of effort. The investigators will test the null hypothesis that sodium citrate ingestion (chronic and acute) will not have an effect on exercise performance compared to placebo.

Detailed description

Anaerobic glycolysis quickly provides adenosine triphosphate (ATP) for muscular contraction during high intensity, short duration exercise. The fast rate of glycolysis during anaerobic exercise results in pyruvate formation exceeding pyruvate oxidation resulting in a build up of lactic acid. Lactic acid dissociates quickly to lactate (La-) and hydrogen ion (H+) which causes a decrease in muscle and blood pH. The increase in H+ causes impaired release of calcium from the sarcoplasmic reticulum and calcium ion binding which inhibits the coupling of actin and myosin. Ingestion of sodium citrate (Na-Cit), an alkalizing agent, increases extracellular pH via liver oxidation by decreasing \[H+\] and increasing bicarbonate concentration (HCO3-). Studies have confirmed that increasing extracellular pH promotes the efflux of La- and H+ from active muscles. This is due to an increase in activity of the pH sensitive monocarboxylate transporter as the gradient of intracellular versus extracellular H+ increases. Therefore, artificially inducing alkalosis prior to anaerobic exercise may reduce intracellular acidosis and increase the time to fatigue - defined as a decrease in force production with an increased perception of effort. Furthermore, Cit- enters the cell through the Plasma Membrane Citrate Transporter and in the cell Cit- is involved in a number of processes: i) intermediary in the Krebs Cycle, ii) transports acetyl-Co-enzyme A (CoA)from the mitochondria to the cytosol for fatty-acid synthesis, iii) negative allosteric effector of phosphofructokinase, iv) anionic effect on membrane potential can cause a reduction in the contraction threshold. Researchers have studied sodium bicarbonate and Na-Cit as potential alkalizing agents. Na-Cit has been studied in few sports over a broad array of doses, times, and distances with inconclusive results. McNaughton et al. researched the optimal doses and durations for Na-Cit to be potentially beneficial to performance. They concluded that 0.3-0.5g/kg, 90-120 minutes prior to maximal effort are the optimal conditions for potential ergogenic effect. The only reported side effect was gastrointestinal (GI) discomfort in a 3 of the 8 subjects. However, it seems Na-Cit is handled better than the more commonly employed sodium bicarbonate. The investigators will test the null hypothesis that sodium citrate ingestion (chronic and acute) will not have an effect on exercise performance compared to placebo.

Interventions

OTHERSodium Citrate Dihydrate

Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic)

Sponsors

Brock University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
13 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 13-17 * Male * Regional, provincial and national level swimmers

Exclusion criteria

* Females * Level of swimming below regional level standards * Caffeine before trials * Chronic health concerns * Health problems before or during the course of the trial

Design outcomes

Primary

MeasureTime frameDescription
Timeonce each 200m performancetime to complete 200 metre swimming performances in seconds Participants chose type of swim stroke to swim a maximal effort 200 metre performance

Secondary

MeasureTime frameDescription
Lactate3 min post performancelactate measured at 3min post trial

Other

MeasureTime frameDescription
Rate of Perceived ExertionRate of Perceived Exertion after each 200m swimming performanceRate of perceived exertion (RPE) was recorded after each 200 metre swimming performance RPE scale is from 6-20. Minimum = 6 (level of exertion equal to lying down) and Maximum = 20 (maximal perceived exertion) Numbers reported are the average of the RPE recorded for all 10 participants.

Countries

Canada

Participant flow

Participants by arm

ArmCount
All Study Participants
Acute: dose: 0.5 g/kg of body mass dissolved in 500 milliliters of flavoured water Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic) Acute Placebo: 500 milliliters flavoured water (placebo for the acute dosing intervention of sodium citrate) Chronic: 3 days of 0.1g/kg of body mass of sodium citrate and 4th day at 0.3 g/kg of body mass of sodium citrate in 500 milliliters of flavoured water Sodium Citrate Dihydrate: Dose sodium citrate dihydrate through 2 dosing protocols (Acute and Chronic) Chronic Placebo: 3 days of 500 milliliters flavoured water and the 4th day 500 milliliters flavoured water (placebo for the chronic dosing intervention of sodium citrate)
10
Total10

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
10 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Region of Enrollment
Canada
10 participants
Sex/Gender, Customized
males
10 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 100 / 100 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 100 / 100 / 10

Outcome results

Primary

Time

time to complete 200 metre swimming performances in seconds Participants chose type of swim stroke to swim a maximal effort 200 metre performance

Time frame: once each 200m performance

ArmMeasureValue (MEAN)Dispersion
Flavoured Water Placebo for Acute DosingTime144.2 secondsStandard Error 4.7
Sodium Citrate Dihydrate AcuteTime145.3 secondsStandard Error 5.3
Flavoured Water Placebo for Chronic DosingTime145.3 secondsStandard Error 5.4
Sodium Citrate Dihydrate ChronicTime144.8 secondsStandard Error 5.3
Secondary

Lactate

lactate measured at 3min post trial

Time frame: 3 min post performance

ArmMeasureValue (MEAN)Dispersion
Flavoured Water Placebo for Acute DosingLactate8.8 mmol/LStandard Error 0.7
Sodium Citrate Dihydrate AcuteLactate10.4 mmol/LStandard Error 1.3
Flavoured Water Placebo for Chronic DosingLactate9.5 mmol/LStandard Error 1.2
Sodium Citrate Dihydrate ChronicLactate10.8 mmol/LStandard Error 1
Other Pre-specified

Rate of Perceived Exertion

Rate of perceived exertion (RPE) was recorded after each 200 metre swimming performance RPE scale is from 6-20. Minimum = 6 (level of exertion equal to lying down) and Maximum = 20 (maximal perceived exertion) Numbers reported are the average of the RPE recorded for all 10 participants.

Time frame: Rate of Perceived Exertion after each 200m swimming performance

ArmMeasureValue (MEAN)Dispersion
Flavoured Water Placebo for Acute DosingRate of Perceived Exertion16.4 units on a scale (6-20)Standard Error 0.6
Sodium Citrate Dihydrate AcuteRate of Perceived Exertion16.1 units on a scale (6-20)Standard Error 0.6
Flavoured Water Placebo for Chronic DosingRate of Perceived Exertion16.6 units on a scale (6-20)Standard Error 0.3
Sodium Citrate Dihydrate ChronicRate of Perceived Exertion17.1 units on a scale (6-20)Standard Error 0.6

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026